These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 17961549

  • 1. The effect of taurolidine on experimental thrombus formation.
    Kaptanoglu L, Kucuk HF, Colak E, Kurt N, Bingul SM, Akyol H, Torlak OA, Yazici F.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):238-41. PubMed ID: 17961549
    [Abstract] [Full Text] [Related]

  • 2. Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis.
    Carelli G, Maffei FH, Mattar L, Ferrari IC, Thomazini-Santos IA, de Carvalho LR.
    Pathophysiol Haemost Thromb; 2005 Jan 14; 34(6):263-8. PubMed ID: 16772737
    [Abstract] [Full Text] [Related]

  • 3. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 14; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
    Bobrich E, Braumann C, Opitz I, Menenakos C, Kristiansen G, Jacobi CA.
    J Surg Res; 2007 Jan 14; 137(1):75-82. PubMed ID: 17109891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C, Yu A, Yuan B, Dong C, Yu H, Wang L, Wu C.
    Thromb Haemost; 2008 Feb 14; 99(2):324-30. PubMed ID: 18278181
    [Abstract] [Full Text] [Related]

  • 9. Intra-abdominal use of taurolidine or heparin as alternative products to an antiadhesive barrier (Seprafilm) in adhesion prevention: an experimental study on mice.
    Bahadir I, Oncel M, Kement M, Sahip Y.
    Dis Colon Rectum; 2007 Dec 14; 50(12):2209-14. PubMed ID: 17902020
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses.
    Monreal L, Villatoro AJ, Monreal M, Espada Y, Anglés AM, Ruiz-Gopegui R.
    Am J Vet Res; 1995 Oct 14; 56(10):1281-5. PubMed ID: 8928943
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ, Oliveira SN, Melo FR, Pereira MG, Benevides NM, Mourão PA.
    Thromb Haemost; 2008 Mar 14; 99(3):539-45. PubMed ID: 18327402
    [Abstract] [Full Text] [Related]

  • 14. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B, Hauptmann J, Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Mar 14; 115(1-2):119-25. PubMed ID: 2459005
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin.
    Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JG, Nielsen G, Hedner U.
    Thromb Haemost; 1994 Feb 14; 71(2):214-9. PubMed ID: 8191401
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ, Gardell SJ, Holahan MA, Sitko GR, Stump GL, Wallace AA, Gilberto DB, Hare TR, Krueger JA, Dyer DL, Sanderson PE, Vacca JP, Shafer JA, Lynch JJ.
    J Pharmacol Exp Ther; 1999 Apr 14; 289(1):503-10. PubMed ID: 10087043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H, Ozbilge H, Oguz E, Gurkan T.
    Curr Eye Res; 2005 Mar 14; 30(3):155-61. PubMed ID: 15804740
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
    Eriksson BI, Carlsson S, Halvarsson M, Risberg B, Mattsson C.
    Thromb Haemost; 1997 Nov 14; 78(5):1404-7. PubMed ID: 9408027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.